Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Views of patients with advanced disease and their relatives on participation in palliative care research

K. Vlckova, K. Polakova, A. Tuckova, A. Houska, M. Loucka

. 2021 ; 20 (1) : 80. [pub] 20210605

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004230

Grantová podpora
17-26722Y Grantová Agentura České Republiky

BACKGROUND: Patients with advanced disease may not be invited to participate in research based on the assumption that participation would be too burdensome for them. The aim of this study was to explore how patients with advanced disease and their relatives evaluate their experience with research participation. METHOD: This study used data from two parts of a larger project. The first dataset was a cross-sectional questionnaire study focused on priorities at the end of life. The second dataset used a longitudinal design with structured interviews on prognostic awareness. In both studies, participants evaluated their experience on a 5-point Likert scale and specified their motivation in an open-ended question. Data were collected in 6 hospitals in the Czech Republic with patients with advanced disease and life expectancy less than 1 year and their relatives. Data were analysed using non-parametric tests and thematic analysis. RESULTS: First dataset consisted of 167 patients and 102 relatives, and second dataset consisted of 135 patients and 92 relatives (in total, 496 respondents). Results were similar in both datasets, with half of the sample (53%, 48%) scoring neutral, and over 30% of the sample identified their experience as interesting. The most significant factors associated with the evaluation were religiosity (p = 0.001) and the type of diagnosis (p = 0.04). Motivation for participation was to improve care, support research, express own opinion, opportunity to talk and trusting relationship. CONCLUSIONS: Patients with advanced disease and relatives do not mind participating in palliative care research, and it can be even a positive experience for them.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004230
003      
CZ-PrNML
005      
20220127145424.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12904-021-00779-2 $2 doi
035    __
$a (PubMed)34090400
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Vlckova, Karolina $u Center, for Palliative Care, Dykova 15, Prague, 110 00, Czech Republic. k.vlckova@paliativnicentrum.cz $u First Faculty of Medicine, Charles University, Prague, Czech Republic. k.vlckova@paliativnicentrum.cz
245    10
$a Views of patients with advanced disease and their relatives on participation in palliative care research / $c K. Vlckova, K. Polakova, A. Tuckova, A. Houska, M. Loucka
520    9_
$a BACKGROUND: Patients with advanced disease may not be invited to participate in research based on the assumption that participation would be too burdensome for them. The aim of this study was to explore how patients with advanced disease and their relatives evaluate their experience with research participation. METHOD: This study used data from two parts of a larger project. The first dataset was a cross-sectional questionnaire study focused on priorities at the end of life. The second dataset used a longitudinal design with structured interviews on prognostic awareness. In both studies, participants evaluated their experience on a 5-point Likert scale and specified their motivation in an open-ended question. Data were collected in 6 hospitals in the Czech Republic with patients with advanced disease and life expectancy less than 1 year and their relatives. Data were analysed using non-parametric tests and thematic analysis. RESULTS: First dataset consisted of 167 patients and 102 relatives, and second dataset consisted of 135 patients and 92 relatives (in total, 496 respondents). Results were similar in both datasets, with half of the sample (53%, 48%) scoring neutral, and over 30% of the sample identified their experience as interesting. The most significant factors associated with the evaluation were religiosity (p = 0.001) and the type of diagnosis (p = 0.04). Motivation for participation was to improve care, support research, express own opinion, opportunity to talk and trusting relationship. CONCLUSIONS: Patients with advanced disease and relatives do not mind participating in palliative care research, and it can be even a positive experience for them.
650    _2
$a průřezové studie $7 D003430
650    _2
$a rodina $7 D005190
650    12
$a hospicová a paliativní ošetřovatelská péče $7 D064946
650    _2
$a lidé $7 D006801
650    12
$a paliativní péče $7 D010166
650    _2
$a kvalitativní výzkum $7 D036301
650    _2
$a průzkumy a dotazníky $7 D011795
655    _2
$a časopisecké články $7 D016428
700    1_
$a Polakova, Kristyna $u Center, for Palliative Care, Dykova 15, Prague, 110 00, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Tuckova, Anna $u Center, for Palliative Care, Dykova 15, Prague, 110 00, Czech Republic $u Faculty of Social Science, Charles University, Prague, Czech Republic
700    1_
$a Houska, Adam $u Center, for Palliative Care, Dykova 15, Prague, 110 00, Czech Republic $u First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Loucka, Martin $u Center, for Palliative Care, Dykova 15, Prague, 110 00, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00008200 $t BMC palliative care $x 1472-684X $g Roč. 20, č. 1 (2021), s. 80
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34090400 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145421 $b ABA008
999    __
$a ok $b bmc $g 1751630 $s 1155379
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 20 $c 1 $d 80 $e 20210605 $i 1472-684X $m BMC palliative care $n BMC Palliat Care $x MED00008200
GRA    __
$a 17-26722Y $p Grantová Agentura České Republiky
LZP    __
$a Pubmed-20220113
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace